|
As Covid-19 cases among children continue to rise, the Food and Drug Administration plans to broaden eligibility for Pfizer-BioNTech booster shots to children ages 12 to 15 in the coming days, a person with knowledge of the plan said. Nearly 199,000 cases among children were reported for the week that ended Dec. 23. |
